Content
08/12/2021 San Diego, CA USA
Debut completed $22.6 million Series A Round funding. Investors include Material Impact (lead), ACVC Partners, Cantos Ventures, Fine Structure Ventures, Humboldt Fund, KdT Ventures.
#Biotech  #Life Science  
About
Debut is pioneering the beauty industry’s shift from traditionally sourced ingredients derived from petroleum and cultivation to high-performing and inherently sustainable biotech ingredients. As a fully vertically-integrated global company, Debut creates superior, scientifically-engineered, bio-based and clinically-proven products and brands at scale to benefit people and planet. Our mission is to create a new beauty standard based on potency, purity, and performance.
Startup
Sector:
Biotech
Life Science
Download StockFan App Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.